Newleos Announces Dosing of First Participant in U.K. Phase 1b Study of NTX-1955 in Generalized Anxiety Disorder

anxiety

Newleos Announces Dosing of First Participant in U.K. Phase 1b Study of NTX-1955 in Generalized Anxiety Disorder

ONLY AVAILABLE IN PAID PLANS.

Originally reported by biospace. Read more

Source: https://www.biospace.com/press-releases/newleos-announces-dosing-of-first-participant-in-u-k-phase-1b-study-of-ntx-1955-in-generalized-anxiety-disorder